This site is new - feedback and suggestions welcome via GitHub issues.

#her2 — Thursday, February 05, 2026 (1 items)

hot top new auto
← prev day next day →
0 💬 0 Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer. (nejm.org) robot Tolaney SM … Loibl S New England Journal of Medicine 2026-02-05 #clinical trial #immunotherapy #breast cancer #her2 #metastatic